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Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer
patients in the UK. It identifies the current evidence base and role of health-related quality of life assessment for
this group of patients.
Recommendations
• Health-related quality of life is integral to treatment planning, refining treatment protocols, and more
personalised follow-up support. (G)
• Health-related quality of life and patient concerns should be regularly assessed during patient care. (G)
• Health-related quality of life assessment and patient concerns on an individual patient basis can be helpful to
trigger multi-professional support and interventions. (G)
The evaluation of the quality of life (QoL) in patients
with head and neck cancer is integral to optimal
patient care.1 Survival is usually the initial primary
concern of patients and the focus is on treatments that
offer the best chance of cure as a priority. However,
after treatment there tends to be a shift towards QoL
and living with the consequences of head and neck
cancer treatment (survivorship).
What is quality of life?
Quality of life is a multifaceted construct comprising
many different aspects leading to numerous definitions.
The World Health Organization defines quality of life
as an “individual’s perception of their position in life
in the context of the culture and value systems in
which they live and in relation to their goals, expecta-
tions, standards and concerns”.2 Quality of life com-
prises a person’s physical health and functioning,
psychological state, level of independence, social rela-
tionships, occupation and finance, and personal beliefs.
There is a complex relationship between factors such as
the characteristics of the individual with respect to
symptoms, personality, motivation, value preferences
and the characteristics of the environment such as
psychological, social and economic support.2 The
term ‘health-related quality of life’ (HRQoL) is more
disease specific and allows the healthcare professions
to focus upon the assessment of the impact of the
disease and its treatment on the physical, psychological
and social aspects.3
Why should we measure quality of life?
Health-related quality of life evaluation gives an indica-
tion of how the patient perceives the impact of their
cancer and its treatment. This information can be
used to give the patient and their family an indication
of ‘what will I be like’.1 This patient reported
outcome allows the health professional an opportunity
to reflect on the patient’s reaction. Individual patient-
rated outcomes can often differ quite markedly from
clinician-rated scores. Health-related quality of life
measurement has a role in evaluating treatment out-
comes, helping to define treatment protocols, as
primary or secondary outcome(s) of clinical trials, pro-
viding additional information to assist in individual
decision-making processes, to support the identifica-
tion of poor outcomes, so that intervention and
support can be considered.4 Checklists such as the
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Patients Concerns Inventory help patients express
unmet concerns and can be used as part of holistic
needs assessment.5 A better understanding of patients’
perception helps facilitate improvements in aftercare
and serves to drive clinically relevant outcomes
research.6 Also patient-reported outcomes should be
part of national outcome datasets.7–9
It is appreciated that there are many potential diffi-
culties in assessing HRQoL in clinical practice.10,11
Perhaps the biggest challenges are: (i) the burden of
administration and processing of the questionnaires;
(ii) the reality that patients tend to adapt over time, so
that expected differences between treatments might
not be as significant as anticipated; (iii) that HRQoL
data are weighted to survivors; and (iv) that there is
little evidence of agreed standards of analysis and
reporting. Another barrier is the lack of evidence as
to when HRQoL should have a major role on treatment
decisions, or an important role simply as an additional
factor, or perhaps where it has relatively little value.
Hence, healthcare professionals can unrealistically
rely too much on the value of HRQoL in certain clin-
ical situations and this can lead to frustration and a
perceived lack of benefit in the HRQoL process.
How should it be measured?
The commonest way to measure HRQoL is by patient
self-completed questionnaire (quantitative) although
other methods include open and semi-structured inter-
view (qualitative).11 There is no gold standard ques-
tionnaire and each has its own unique features and
merits.12–14 All questionnaires are inherently limited
by the range of issues addressed, the wording used,
and the scoring systems. The choice of questionnaire
depends on the reason for using it, e.g. research,
audit, integrated into routine clinical practice or to
assist in the evaluation of a specific functional
outcome.15
Questionnaires can be used either cross-sectionally
or longitudinally. Longitudinal data from pre-treatment
has the distinct advantage of allowing the measurement
of change and also recording HRQoL during the differ-
ent phases of treatment. It is a logistical challenge to
ensure patients self-complete questionnaires before
treatment and at regular intervals subsequently.
Cross-sectional evaluation is simpler to conduct and
easier to achieve larger patient numbers when stratify-
ing for patient characteristics. Questionnaires can be
divided into four main categories: (i) those asking on
a range of broad issues not specific to cancer; (ii)
those addressing issues common to all cancers; (iii)
questionnaires with items specific to head and neck
cancer; and (iv) those questionnaires that focus in
detail on a particular aspect of head and neck function.9
With changes in treatments e.g. epidermal growth
factor receptor inhibitors as part of chemotherapy, so
existing HRQoL questionnaires might need to be
modified to include additional side effects and func-
tional deficits. As the relationship between unmet
need and HRQoL becomes more clearly understood,
further consideration needs to be given as to how,
within the financial constraints of cancer care, ques-
tionnaires can be more easily integrated into routine
practice. Advances in technology will assist in the col-
lection and inclusion of patient-reported outcomes.
The almost ubiquitous ownership of mobile phones
allows developers in partnership with clinical research-
ers to construct ‘Apps’ that can send alerts to patients
for HRQoL updates on certain features. This is an
exciting area that is in its infancy but holds great
promise to enable a more comprehensive, flexible
and frequent opportunity to explore, study and inter-
vene in patient HRQoL.
What are the key issues?
There are a considerable range of issues that impact on
the HRQoL outcomes following head and neck cancer.
This section makes only very brief comment on the
type of issues involved (listed in alphabetical order).
There are several review articles that give additional
information.12–14,16,17 At the present time there tends
to be a lack of long-term outcomes reported in the lit-
erature. Also newer treatment strategies are under
reported given the time necessary to get adequate
HRQoL information.
• Carer: there is a need to promote positive carer
support; carers can underestimate the HRQoL
outcome
• Comorbidity: patient perception of disability,
rather than the extent and severity of disease is
of major influence in head and neck HRQoL
• Coping: social support seeking is beneficial whilst
avoidance is bad
• Dental status: eating – social interaction and is
linked to coping
• Disfigurement: appearance, body image, not only
an issue in surgical patients
• Emotion: anxiety is high pre-treatment; mood dis-
turbance and/or depression is treatable
• Family and children: the impact of cancer affects
family and community
• Fatigue: common in the first year post-treatment;
poor sleep; low energy
• Fear of recurrence: unpredictable by clinical
characteristics; does not lessen over time; and
high levels predict higher consumption of formal
healthcare.
• Financial and work: employment; benefits; cost of
treatment and follow-up; and retirement
• Function: pre-existing comorbidities; problems of
combination treatment modalities – impact on
recreation, hobbies, interests. In general, the less
the consequence of the cancer and its treatment
in terms of social function the better the HRQoL
outcomes
• Fungating wounds: difficulties in palliation in
head and neck; relatively few published papers
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• Information: varying amounts, in various ways, at
different times the importance of communication
skills and consistency of contact with named
health professional for duration of clinical treatment;
also access to patient and career support groups
• Intimacy: sexuality, worst in the younger patient
as an unmet need
• Lifestyle choices: smoking; alcohol abuse
• Nutrition: low weight; diet; gastrostomy feeding
• Oral rehabilitation: chewing and/or eating – realis-
tic expectations of rehabilitation
• Osteoradionecrosis: associated with pain; trismus;
poor HRQoL; and nutrition problems
• Pain: need for opiates; poor sleep; linked with
depression
• Personality: optimism and HRQoL and survival;
high neuroticism poor HRQoL
• Self-esteem: social concerns; reactions of friends,
wider community, work colleague; low self-
esteem associated with poor HRQoL
• Sociodemographic: deprivation and social support;
age; and finance
• Speech: complex function; various aspects; laryn-
geal speech outcomes; isolation
• Swallowing: nutrition; social; presence of feeding
tube most significant to HRQOL
• Shoulder: shoulder discomfort and neck tightness;
debate around avoiding a neck dissection or carry-
ing out a selective dissection
• Trismus: difficulty in mouth opening associated
with diet, social, and dental health
• Unknown: clinical art of the individual patient not
a precise science
• Xerostomia: dry mouth has a profound impact on
social function and HRQoL, intensity modulated
radiation therapy should be used whenever feasible.
Examples of how HRQoL might change
practice
Health-related quality of life is a factor that is weighed
against treatment burden and toxicity, and also any sur-
vival benefit between treatments. In the three common
head and neck cancer sites, HRQoL might be a driver
for evolving strategies alongside other drivers such as
survival, function and healthcare cost. Examples are
described below.
Oropharynx
1. Early stage disease: There is an argument for
transoral excision for early oropharynx lesions
with selective neck dissection. This avoids the
need for free tissue transfer and access procedures
such as lip split mandibulotomy.
Drivers for change: Health-related quality of life,
survival, function, cost to National Health
Service (reduced length of stay).
2. Advanced stage disease: Chemoradiotherapy is
often advocated for larger oropharyngeal primaries
if laser resection is not possible. The long-term
outcomes remain unclear as does the success of
salvage surgery and its impact on HRQoL. The
benefit of salvage surgery and the impact on
HRQoL is currently unclear. Transoral surgery is
problematic due to the high-risk of local necrosis,
non-healing and catastrophic bleeding. The use of
free flap reconstruction in the post-chemora-
diotherapy failures, is often associated with poor
functional outcomes, poor HRQoL and limited
cure rates.
Drivers for change: Health-related quality of life;
function; healthcare cost.
3. Human papilloma virus (HPV) testing: It is con-
ceivable that it is possible to de-escalate treatment
in some HPV positive patients. Similar survival
outcomes may be achieved by the use of cetuxi-
mab and radiotherapy rather than platinum-
based chemoradiotherapy.
Drivers for change: Health-related quality of life.
Larynx
1. Early stage disease: Laser excision rather than
primary radiotherapy for suitable lesions.
Drivers for change: Patient choice based on
equivalent HRQoL and survival.
2. Advanced stage disease: There is debate about
chemoradiotherapy or laryngectomy. Following
chemoradiotherapy the success and impact of lar-
yngectomy for salvage remains to be fully deter-
mined.
Drivers for change: Health-related quality of life,
survival.
Oral cavity
1. Early stage disease: There is a rationale towards
primary surgery without free tissue reconstruc-
tion accepting close margins with low risk of
local recurrence
Drivers for change: Health-related quality of life,
survival, function, cost of overall treatment.
2. Advanced stage disease: Primary surgery with
free tissue reconstruction as required. However,
there is discussion around the benefit of adjuvant
radiotherapy.
Drivers for change: Health-related quality of life,
survival.
Conclusion
The place of HRQoL assessment in head and neck
cancer practice has become more defined in the last
decade. It has had a major role in helping to shape treat-
ment strategies and patient support. More evidence is
yet to emerge to improve guidance as to how to use
HRQoL at an individual patient level and also reflect
the trade off between marginal survival improvements
and increased treatment burden and poorer HRQoL.
Advances in information technology will make it
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easier for HRQoL to assist in decision making, delivery
of information, identification of problem areas, the iden-
tification of risk groups, and to drive support and inter-
ventions aimed at improving the HRQoL outcomes.
Recommendations
• Health-related quality of life is integral to
treatment planning, refining treatment
protocols, and more personalised follow-up
support (G)
• Health-related quality of life and patient
concerns should be regularly assessed during
patient care (G)
• Health-related quality of life assessment and
patient concerns on an individual patient
basis can be helpful to trigger multi-
professional support and interventions (G)
Directions for the future
1. Holistic assessment integrated into clinical prac-
tice and patient reported outcomes reported in
national datasets.
2. Survivorship issues addressed through interven-
tions and empowering patients to develop skills
and confidence for self-management.
3. Evidence base related to interventions, e.g.
AFTER intervention for fear of recurrence.
4. A better understanding of late effects of treatment.
5. Partnership and marital issues are no doubt of sig-
nificant importance, as well as grandparents and
children (family). Interventions need to include
couple therapy and family therapy and practi-
tioners need to be trained in these approaches as
well as individual counselling etc.
6. Wider use of information technology to allow
HRQoL and patient concerns to be more readily
available in clinics and across the multi-profes-
sional team.
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